<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>15: Are international clinical trials exploitative? </title><style>
/* webkit printing magic: print all background colors */
html {
	-webkit-print-color-adjust: exact;
}
* {
	box-sizing: border-box;
	-webkit-print-color-adjust: exact;
}

html,
body {
	margin: 0;
	padding: 0;
}
@media only screen {
	body {
		margin: 2em auto;
		max-width: 900px;
		color: rgb(55, 53, 47);
	}
}

body {
	line-height: 1.5;
	white-space: pre-wrap;
}

a,
a.visited {
	color: inherit;
	text-decoration: underline;
}

.pdf-relative-link-path {
	font-size: 80%;
	color: #444;
}

h1,
h2,
h3 {
	letter-spacing: -0.01em;
	line-height: 1.2;
	font-weight: 600;
	margin-bottom: 0;
}

.page-title {
	font-size: 2.5rem;
	font-weight: 700;
	margin-top: 0;
	margin-bottom: 0.75em;
}

h1 {
	font-size: 1.875rem;
	margin-top: 1.875rem;
}

h2 {
	font-size: 1.5rem;
	margin-top: 1.5rem;
}

h3 {
	font-size: 1.25rem;
	margin-top: 1.25rem;
}

.source {
	border: 1px solid #ddd;
	border-radius: 3px;
	padding: 1.5em;
	word-break: break-all;
}

.callout {
	border-radius: 3px;
	padding: 1rem;
}

figure {
	margin: 1.25em 0;
	page-break-inside: avoid;
}

figcaption {
	opacity: 0.5;
	font-size: 85%;
	margin-top: 0.5em;
}

mark {
	background-color: transparent;
}

.indented {
	padding-left: 1.5em;
}

hr {
	background: transparent;
	display: block;
	width: 100%;
	height: 1px;
	visibility: visible;
	border: none;
	border-bottom: 1px solid rgba(55, 53, 47, 0.09);
}

img {
	max-width: 100%;
}

@media only print {
	img {
		max-height: 100vh;
		object-fit: contain;
	}
}

@page {
	margin: 1in;
}

.collection-content {
	font-size: 0.875rem;
}

.column-list {
	display: flex;
	justify-content: space-between;
}

.column {
	padding: 0 1em;
}

.column:first-child {
	padding-left: 0;
}

.column:last-child {
	padding-right: 0;
}

.table_of_contents-item {
	display: block;
	font-size: 0.875rem;
	line-height: 1.3;
	padding: 0.125rem;
}

.table_of_contents-indent-1 {
	margin-left: 1.5rem;
}

.table_of_contents-indent-2 {
	margin-left: 3rem;
}

.table_of_contents-indent-3 {
	margin-left: 4.5rem;
}

.table_of_contents-link {
	text-decoration: none;
	opacity: 0.7;
	border-bottom: 1px solid rgba(55, 53, 47, 0.18);
}

table,
th,
td {
	border: 1px solid rgba(55, 53, 47, 0.09);
	border-collapse: collapse;
}

table {
	border-left: none;
	border-right: none;
}

th,
td {
	font-weight: normal;
	padding: 0.25em 0.5em;
	line-height: 1.5;
	min-height: 1.5em;
	text-align: left;
}

th {
	color: rgba(55, 53, 47, 0.6);
}

ol,
ul {
	margin: 0;
	margin-block-start: 0.6em;
	margin-block-end: 0.6em;
}

li > ol:first-child,
li > ul:first-child {
	margin-block-start: 0.6em;
}

ul > li {
	list-style: disc;
}

ul.to-do-list {
	text-indent: -1.7em;
}

ul.to-do-list > li {
	list-style: none;
}

.to-do-children-checked {
	text-decoration: line-through;
	opacity: 0.375;
}

ul.toggle > li {
	list-style: none;
}

ul {
	padding-inline-start: 1.7em;
}

ul > li {
	padding-left: 0.1em;
}

ol {
	padding-inline-start: 1.6em;
}

ol > li {
	padding-left: 0.2em;
}

.mono ol {
	padding-inline-start: 2em;
}

.mono ol > li {
	text-indent: -0.4em;
}

.toggle {
	padding-inline-start: 0em;
	list-style-type: none;
}

/* Indent toggle children */
.toggle > li > details {
	padding-left: 1.7em;
}

.toggle > li > details > summary {
	margin-left: -1.1em;
}

.selected-value {
	display: inline-block;
	padding: 0 0.5em;
	background: rgba(206, 205, 202, 0.5);
	border-radius: 3px;
	margin-right: 0.5em;
	margin-top: 0.3em;
	margin-bottom: 0.3em;
	white-space: nowrap;
}

.collection-title {
	display: inline-block;
	margin-right: 1em;
}

time {
	opacity: 0.5;
}

.icon {
	display: inline-block;
	max-width: 1.2em;
	max-height: 1.2em;
	text-decoration: none;
	vertical-align: text-bottom;
	margin-right: 0.5em;
}

img.icon {
	border-radius: 3px;
}

.user-icon {
	width: 1.5em;
	height: 1.5em;
	border-radius: 100%;
	margin-right: 0.5rem;
}

.user-icon-inner {
	font-size: 0.8em;
}

.text-icon {
	border: 1px solid #000;
	text-align: center;
}

.page-cover-image {
	display: block;
	object-fit: cover;
	width: 100%;
	height: 30vh;
}

.page-header-icon {
	font-size: 3rem;
	margin-bottom: 1rem;
}

.page-header-icon-with-cover {
	margin-top: -0.72em;
	margin-left: 0.07em;
}

.page-header-icon img {
	border-radius: 3px;
}

.link-to-page {
	margin: 1em 0;
	padding: 0;
	border: none;
	font-weight: 500;
}

p > .user {
	opacity: 0.5;
}

td > .user,
td > time {
	white-space: nowrap;
}

input[type="checkbox"] {
	transform: scale(1.5);
	margin-right: 0.6em;
	vertical-align: middle;
}

p {
	margin-top: 0.5em;
	margin-bottom: 0.5em;
}

.image {
	border: none;
	margin: 1.5em 0;
	padding: 0;
	border-radius: 0;
	text-align: center;
}

.code,
code {
	background: rgba(135, 131, 120, 0.15);
	border-radius: 3px;
	padding: 0.2em 0.4em;
	border-radius: 3px;
	font-size: 85%;
	tab-size: 2;
}

code {
	color: #eb5757;
}

.code {
	padding: 1.5em 1em;
}

.code-wrap {
	white-space: pre-wrap;
	word-break: break-all;
}

.code > code {
	background: none;
	padding: 0;
	font-size: 100%;
	color: inherit;
}

blockquote {
	font-size: 1.25em;
	margin: 1em 0;
	padding-left: 1em;
	border-left: 3px solid rgb(55, 53, 47);
}

.bookmark {
	text-decoration: none;
	max-height: 8em;
	padding: 0;
	display: flex;
	width: 100%;
	align-items: stretch;
}

.bookmark-title {
	font-size: 0.85em;
	overflow: hidden;
	text-overflow: ellipsis;
	height: 1.75em;
	white-space: nowrap;
}

.bookmark-text {
	display: flex;
	flex-direction: column;
}

.bookmark-info {
	flex: 4 1 180px;
	padding: 12px 14px 14px;
	display: flex;
	flex-direction: column;
	justify-content: space-between;
}

.bookmark-image {
	width: 33%;
	flex: 1 1 180px;
	display: block;
	position: relative;
	object-fit: cover;
	border-radius: 1px;
}

.bookmark-description {
	color: rgba(55, 53, 47, 0.6);
	font-size: 0.75em;
	overflow: hidden;
	max-height: 4.5em;
	word-break: break-word;
}

.bookmark-href {
	font-size: 0.75em;
	margin-top: 0.25em;
}

.sans { font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Helvetica, "Apple Color Emoji", Arial, sans-serif, "Segoe UI Emoji", "Segoe UI Symbol"; }
.code { font-family: "SFMono-Regular", Consolas, "Liberation Mono", Menlo, Courier, monospace; }
.serif { font-family: Lyon-Text, Georgia, YuMincho, "Yu Mincho", "Hiragino Mincho ProN", "Hiragino Mincho Pro", "Songti TC", "Songti SC", "SimSun", "Nanum Myeongjo", NanumMyeongjo, Batang, serif; }
.mono { font-family: iawriter-mono, Nitti, Menlo, Courier, monospace; }
.pdf .sans { font-family: Inter, -apple-system, BlinkMacSystemFont, "Segoe UI", Helvetica, "Apple Color Emoji", Arial, sans-serif, "Segoe UI Emoji", "Segoe UI Symbol", 'Twemoji', 'Noto Color Emoji', 'Noto Sans CJK SC', 'Noto Sans CJK KR'; }

.pdf .code { font-family: Source Code Pro, "SFMono-Regular", Consolas, "Liberation Mono", Menlo, Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK SC', 'Noto Sans Mono CJK KR'; }

.pdf .serif { font-family: PT Serif, Lyon-Text, Georgia, YuMincho, "Yu Mincho", "Hiragino Mincho ProN", "Hiragino Mincho Pro", "Songti TC", "Songti SC", "SimSun", "Nanum Myeongjo", NanumMyeongjo, Batang, serif, 'Twemoji', 'Noto Color Emoji', 'Noto Sans CJK SC', 'Noto Sans CJK KR'; }

.pdf .mono { font-family: PT Mono, iawriter-mono, Nitti, Menlo, Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK SC', 'Noto Sans Mono CJK KR'; }

.highlight-default {
}
.highlight-gray {
	color: rgb(155,154,151);
}
.highlight-brown {
	color: rgb(100,71,58);
}
.highlight-orange {
	color: rgb(217,115,13);
}
.highlight-yellow {
	color: rgb(223,171,1);
}
.highlight-teal {
	color: rgb(15,123,108);
}
.highlight-blue {
	color: rgb(11,110,153);
}
.highlight-purple {
	color: rgb(105,64,165);
}
.highlight-pink {
	color: rgb(173,26,114);
}
.highlight-red {
	color: rgb(224,62,62);
}
.highlight-gray_background {
	background: rgb(235,236,237);
}
.highlight-brown_background {
	background: rgb(233,229,227);
}
.highlight-orange_background {
	background: rgb(250,235,221);
}
.highlight-yellow_background {
	background: rgb(251,243,219);
}
.highlight-teal_background {
	background: rgb(221,237,234);
}
.highlight-blue_background {
	background: rgb(221,235,241);
}
.highlight-purple_background {
	background: rgb(234,228,242);
}
.highlight-pink_background {
	background: rgb(244,223,235);
}
.highlight-red_background {
	background: rgb(251,228,228);
}
.block-color-default {
	color: inherit;
	fill: inherit;
}
.block-color-gray {
	color: rgba(55, 53, 47, 0.6);
	fill: rgba(55, 53, 47, 0.6);
}
.block-color-brown {
	color: rgb(100,71,58);
	fill: rgb(100,71,58);
}
.block-color-orange {
	color: rgb(217,115,13);
	fill: rgb(217,115,13);
}
.block-color-yellow {
	color: rgb(223,171,1);
	fill: rgb(223,171,1);
}
.block-color-teal {
	color: rgb(15,123,108);
	fill: rgb(15,123,108);
}
.block-color-blue {
	color: rgb(11,110,153);
	fill: rgb(11,110,153);
}
.block-color-purple {
	color: rgb(105,64,165);
	fill: rgb(105,64,165);
}
.block-color-pink {
	color: rgb(173,26,114);
	fill: rgb(173,26,114);
}
.block-color-red {
	color: rgb(224,62,62);
	fill: rgb(224,62,62);
}
.block-color-gray_background {
	background: rgb(235,236,237);
}
.block-color-brown_background {
	background: rgb(233,229,227);
}
.block-color-orange_background {
	background: rgb(250,235,221);
}
.block-color-yellow_background {
	background: rgb(251,243,219);
}
.block-color-teal_background {
	background: rgb(221,237,234);
}
.block-color-blue_background {
	background: rgb(221,235,241);
}
.block-color-purple_background {
	background: rgb(234,228,242);
}
.block-color-pink_background {
	background: rgb(244,223,235);
}
.block-color-red_background {
	background: rgb(251,228,228);
}
.select-value-color-default { background-color: rgba(206,205,202,0.5); }
.select-value-color-gray { background-color: rgba(155,154,151, 0.4); }
.select-value-color-brown { background-color: rgba(140,46,0,0.2); }
.select-value-color-orange { background-color: rgba(245,93,0,0.2); }
.select-value-color-yellow { background-color: rgba(233,168,0,0.2); }
.select-value-color-green { background-color: rgba(0,135,107,0.2); }
.select-value-color-blue { background-color: rgba(0,120,223,0.2); }
.select-value-color-purple { background-color: rgba(103,36,222,0.2); }
.select-value-color-pink { background-color: rgba(221,0,129,0.2); }
.select-value-color-red { background-color: rgba(255,0,26,0.2); }

.checkbox {
	display: inline-flex;
	vertical-align: text-bottom;
	width: 16;
	height: 16;
	background-size: 16px;
	margin-left: 2px;
	margin-right: 5px;
}

.checkbox-on {
	background-image: url("data:image/svg+xml;charset=UTF-8,%3Csvg%20width%3D%2216%22%20height%3D%2216%22%20viewBox%3D%220%200%2016%2016%22%20fill%3D%22none%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%3E%0A%3Crect%20width%3D%2216%22%20height%3D%2216%22%20fill%3D%22%2358A9D7%22%2F%3E%0A%3Cpath%20d%3D%22M6.71429%2012.2852L14%204.9995L12.7143%203.71436L6.71429%209.71378L3.28571%206.2831L2%207.57092L6.71429%2012.2852Z%22%20fill%3D%22white%22%2F%3E%0A%3C%2Fsvg%3E");
}

.checkbox-off {
	background-image: url("data:image/svg+xml;charset=UTF-8,%3Csvg%20width%3D%2216%22%20height%3D%2216%22%20viewBox%3D%220%200%2016%2016%22%20fill%3D%22none%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%3E%0A%3Crect%20x%3D%220.75%22%20y%3D%220.75%22%20width%3D%2214.5%22%20height%3D%2214.5%22%20fill%3D%22white%22%20stroke%3D%22%2336352F%22%20stroke-width%3D%221.5%22%2F%3E%0A%3C%2Fsvg%3E");
}
	
</style></head><body><article id="c6a3186c-5245-4425-9aa2-080d08446cc3" class="page sans"><header><img class="page-cover-image" src="https://images.unsplash.com/photo-1575468332949-4bd46064dd66?ixlib=rb-1.2.1&amp;q=85&amp;fm=jpg&amp;crop=entropy&amp;cs=srgb&amp;ixid=eyJhcHBfaWQiOjYzOTIxfQ" style="object-position:center 58.67%"/><h1 class="page-title">15: Are international clinical trials exploitative? </h1></header><div class="page-body"><p id="029cd49d-f1fe-4fd0-ac4a-743cab43f1f7" class="">The question of ethics of international clinical trails is a pertinent one in the context of ongoing COVID 19 vaccine trials. As noted, instances of wrong doing and unethical behaviours exist are not merely a thing of the past. </p><p id="19cbd4a2-5923-4bf6-b155-4da5b5977879" class="">The examples of Tuskegee syphilis experiment which denied available treatments to patients for observing long term effects, STD research in Guatemala where prisoners were infected on purpose and meningitis drug development of Pfizer through uninformed consent in Africa speak to the tragedies of biomedical research ethics. </p><p id="cec1c2a7-958a-4ccb-8eb5-6ecf88f27f5d" class="">International clinical trails despite many benefits, are problematic for a few reasons:</p><ol id="9c7430ce-3db1-4b4d-94c6-fbf2535c0d39" class="numbered-list" start="1"><li>Many of the people who sign up for such experimental trials are from <strong>vulnerable communities</strong>- uneducated, poor and uninsured. In such cases the experimental trial might be their only choice to avoid certain death. Many may not fully comprehend the risks they are putting themselves true in their pursuit of a cure. </li></ol><ol id="8830c3c7-188c-42d4-ab77-2e12afb4e7f4" class="numbered-list" start="2"><li>This points to the larger issue of <strong>possible exploitation</strong>. Exploitation, in my personal opinion, is when one party benefits immensely from another through a process they would not subject themselves to. The definition is not a stand alone or a formal one and needs to be re-evaluated on a case to case basis. </li></ol><p id="405a161a-805e-4fbb-a117-45f6474bfdba" class="">But, we still can provide a few markers for ethically dubious trials such as: when the person agreeing to such a trail does so because they lack any other options, when consent is obtained without fully informing the subject and when the consenting party is not in a position to refuse the needs of the researchers. Further, it must exclude, children and mentally disabled individuals, who lack the rational capacity to make such decisions. </p><p id="307a904c-6ac7-4c92-a9e9-59eb8b57e96e" class="">Often, medical trials are conducted in <strong>developing countries</strong> by companies or researchers from developed countries. This might be because the incidence of a disease might be higher in that region. However, the motivations might also be sinister- fewer or less stringent government regulations, large profit margins and personal fame or benefits. Further in the absence of independent oversight committees there is practically few ways to reprimand any unethical behaviors. </p><p id="0107d308-ae0d-4971-90ed-e3ba839ddb3a" class="">This also points us to the question of how should consent be taken? </p><p id="8644b396-1708-46e4-b886-91f7cd84d6ed" class=""><strong>Genuine consent</strong>  needs the subjects to be informed of the possible effects in a clear and comprehensible manner preferably, in their native language and then obtaining the required documentation. Moreover, one needs to be aware of the cultural &amp; political contexts of the individuals and their capacity to disagree and seek reparations. In the absence of these, the room for exploration is plenty. </p><p id="d608bfd3-6c80-47b3-9d44-f23b77309290" class="">In situations where is an <strong>urgency of need</strong>, such as the current pandemic situation, medicines developed through trials on a community should seek to benefit the local community first and pass through rigorous testing beforehand. </p><p id="b8bb5c94-5e73-4adf-8cb7-2b08c2701d78" class="">All these issues make the problem appear like the classic ethical dilemma of the trolley problem : can a few 100 people be killed for potentially saving a million lives? </p><p id="46388033-7890-4921-93fb-88f9b898d388" class="">However, given the indispensable nature of international critical trials we can lessen the two evils through <strong>education and legislation</strong>. </p><p id="808de3d8-cfd2-45cc-a6ac-6c8c76c5ae8b" class="">Doctors and researchers must be <strong>educated on the ethics of medicine </strong>given that a lot rides on their individual moral discretion and interpretation.  However at the same time, <strong>legislation</strong> needs to curb the possibility of exploitation and unethical behaviors. Laws such as that of WHO which requires the researchers to use the same guidelines as that of their home community need to be drafted and implemented at an international level. Independent oversight committees need to be constituted with sufficient funding to prevent exploitation in prisons or developing nations. </p><p id="7bae3631-254e-44b0-9d98-7d144485c151" class="">However, we must also address the <strong>issue of vulnerability</strong>. Even the most well-crafted legislations and oversight committees can fail. Uneducated or poor people must be informed about their rights and be provided with better access to legal reparations. Additionally, they must not incur any uncompensated losses and terms for the same must be included in consent documents. </p><p id="c5f9dd0f-6e11-4902-b057-1d5d0488e16e" class="">These measures could prevent any terrible consequences or incidences of unethical research trails and ensure that in the long term, no community remains completely vulnerable to exploitation. </p><p id="4f3ab5b9-81a9-49b5-89ab-47468de4bb7b" class="">
</p><hr id="14bc14ba-f908-4f7b-b737-27bd83e985b3"/><p id="b4590fac-c50e-449a-9f4c-bfd9eec7c0b3" class="">
</p></div></article></body></html>